| Views | |
|---|---|
| CD206-Targeted Liposomal Myelin Basic Protein Peptides in Patients with Multiple Sclerosis Resistant to First-Line Disease-Modifying Therapies: A First-in-Human, Proof-of-Concept Dose-Escalation Study | 99 |
| December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | May 2024 | June 2024 | |
|---|---|---|---|---|---|---|---|
| CD206-Targeted Liposomal Myelin Basic Protein Peptides in Patients with Multiple Sclerosis Resistant to First-Line Disease-Modifying Therapies: A First-in-Human, Proof-of-Concept Dose-Escalation Study | 0 | 5 | 8 | 1 | 3 | 1 | 1 |
| Views | |
|---|---|
| SCOPUS19337213-2016-SID84975221908-a1.pdf | 7 |
| Views | |
|---|---|
| Russia | 78 |
| Views | |
|---|---|
| Kazan | 78 |